More about

Emory University

News
May 16, 2019
11 min read
Save

The Take Home: ACC

The American College of Cardiology Scientific Session produced some groundbreaking findings with major implications for the practice of interventional cardiology. Most stunning was two trials that showed transcatheter aortic valve replacement bested surgery in low-risk patients with severe aortic stenosis; reaction to those data appears in the Cover Story.

News
May 15, 2019
4 min read
Save

Lenalidomide delays progression of smoldering myeloma

Early treatment with lenalidomide significantly reduced the risk for progression of high-risk smoldering multiple myeloma to symptomatic multiple myeloma, according to results of a randomized trial scheduled for presentation at ASCO Annual Meeting.

News
April 24, 2019
2 min read
Save

Recent insurance policy changes for depression tied to increased treatment

Recent policy changes enacted between 1998 and 2015 to expand insurance coverage for mental health services was associated with increased prevalence of depression treatment without increasing prices or total spending, according to a study published in JAMA Psychiatry.

News
April 24, 2019
4 min watch
Save

VIDEO: Novel combinations can capitalize on immunogenicity of head and neck cancer

NEW YORK — Nabil F. Saba, MD, FACP, professor of hematology/medical oncology and otolaryngology and director of the head and neck oncology program at Winship Cancer Institute at Emory University, spoke at HemOnc Today New York about combination approaches for head and neck squamous cell carcinoma in the immunotherapy era.

News
April 11, 2019
3 min read
Save

Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer

Maintenance treatment with combination nivolumab/ipilimumab or nivolumab alone did not improve OS compared with placebo in patients with extensive-stage small cell lung cancer, according to results from the phase 3 CheckMate 451 study presented at European Lung Cancer Congress.

News
April 10, 2019
2 min read
Save

FDA grants breakthrough therapy designation for ticagrelor reversal agent

The FDA has granted breakthrough therapy designation for a novel reversal agent for the antiplatelet drug ticagrelor, according to an announcement from PhaseBio Pharmaceuticals Inc.

News
April 02, 2019
5 min read
Save

Osimertinib plus intermittent selumetinib shows preliminary activity in EGFR-mutated lung cancer

ATLANTA — Osimertinib plus intermittent selumetinib demonstrated preliminary antitumor activity and acceptable toxicity in patients with EGFR-mutated non-small cell lung cancer whose disease progressed during prior treatment with an EGFR tyrosine kinase inhibitor, according to results of the phase 1b TATTON study presented at American Association for Cancer Research Annual Meeting.

News
March 18, 2019
4 min read
Save

Monovision via LASIK or inlay: A presbyopia debate

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

News
March 14, 2019
2 min read
Save

Heart health awareness not strong in young women

Most adolescent and young women are unaware that heart disease is the leading cause of death in women in the United States, according to a survey presented at the American Heart Association Epidemiology, Prevention, Lifestyle and Cardiometabolic Health Scientific Sessions.

News
February 25, 2019
3 min read
Save

Living in food deserts confers elevated CV risk in CAD

Increased risk for adverse CV events in adults with CAD is associated with living in food deserts, with adults living in low-income areas having significantly worse outcomes, according to findings published in the Journal of the American Heart Association.

View more